glp-1 trial results today 3 Takeaways from the Landmark Oral 'Switch' for Obesity Care 📢 ATTAIN-1 trial results for

Description

What Happens If You Dont Get Enough: You might have weak bones, muscle cramps, or trouble sleeping

[DOI] [PubMed] [Google Scholar] 69.ONeil PM, et al

Another research found that therapy with exenatide may decrease oxidative stress and upregulate anti-inflammatory responses in the peripheral lymphocytes of type 1 and T2D patients

The GLP-1 receptor agonist exenatide ameliorates neuroinflammation, locomotor activity, and anxiety-like behavior in mice with diet-induced obesity through the modulation of microglial M2 polarization and downregulation of SR-A4

GIP and GLP-1 then bind to their specific receptors which cause reactions thereby stimulating insulin secretion to move the glucose from the blood stream to the muscles and other cells where it can be used as well as having other effects throughout the body such as increasing fullness and satiety